These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36244331)

  • 1. Comparison of Mirabegron plus Tamsulosin and Tamsulosin Monotherapy for the Treatment of Ureteral Stent-Related Symptoms: A Prospective Randomized Study.
    Zhang K; Yan W; Li H; Chen J; Wang Q; Chai Y; Yuan L; Zhu G
    Urol Int; 2022; 106(12):1226-1232. PubMed ID: 36244331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of stent related symptoms in patients taking mirabegron, solifenacin, or tamsulosin: A double blinded randomized clinical trial.
    Chandna A; Kumar S; Parmar KM; Sharma AP; Devana SK; Mete UK; Singh SK
    Urologia; 2022 Nov; 89(4):589-596. PubMed ID: 34596484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamsulosin Versus Mirabegron in Relieving Ureteric Stent-Related Symptoms: A Prospective, Double-Blinded, Randomized Controlled Trial.
    Javid M; Abdullah A; Ganapathy R; Gupta YB; Selvaraj S; Ilangovan AK; Sivalingam S; Prasad S
    Cureus; 2023 Dec; 15(12):e50502. PubMed ID: 38222169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does tamsulosin or mirabegron improve ureteral stent-related symptoms? A prospective placebo-controlled study.
    Yavuz A; Kilinc MF; Aydin M; Ofluoglu Y; Bayar G
    Low Urin Tract Symptoms; 2021 Jan; 13(1):17-21. PubMed ID: 32408390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does mirabegron relieve ureteric stent-related discomfort? A prospective, randomized, multicentre study.
    Tae BS; Cho S; Jeon BJ; Choi H; Park JY; Cho SY; Lee KC; Bae JH
    BJU Int; 2018 Nov; 122(5):866-872. PubMed ID: 29802800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial.
    Sivalingam S; Streeper NM; Sehgal PD; Sninsky BC; Best SL; Nakada SY
    J Urol; 2016 Feb; 195(2):385-90. PubMed ID: 26393904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.
    El-Nahas AR; Tharwat M; Elsaadany M; Mosbah A; Gaballah MA
    World J Urol; 2016 Jul; 34(7):963-8. PubMed ID: 26453222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tamsulosin hydrochloride in relieving "double-J ureteral stent-related morbidity": a randomized placebo controlled clinical study.
    Singh I; Tripathy S; Agrawal V
    Int Urol Nephrol; 2014 Dec; 46(12):2279-83. PubMed ID: 25201459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2 × 2 factorial randomized trial.
    Park J; Yoo C; Han DH; Shin DW
    World J Urol; 2015 Nov; 33(11):1833-40. PubMed ID: 25809877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ureteral catheter related symptoms; mirabegron versus tamsulosin/solifenacin combination: A randomized controlled trial.
    Sahin A; Yildirim C; Yuksel OH; Urkmez A
    Arch Esp Urol; 2020 Jan; 73(1):54-59. PubMed ID: 31950924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study.
    Wang CJ; Huang SW; Chang CH
    Urol Res; 2009 Jun; 37(3):147-52. PubMed ID: 19277623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Tamsulosin, Oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms.
    Maldonado-Avila M; Garduno-Arteaga L; Jungfermann-Guzman R; Manzanilla-Garcia HA; Rosas-Nava E; Procuna-Hernandez N; Vela-Mollinedo A; Almazan-Trevino L; Guzman-Esquivel J
    Int Braz J Urol; 2016; 42(3):487-93. PubMed ID: 27286111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirabegron for the Treatment of Ureteral Stent-related Symptoms: A Systematic Review and Meta-analysis.
    Van Besien J; Keller EX; Somani B; Pietropaolo A; Claessens M; Merckx L; Tailly T; De Coninck V
    Eur Urol Focus; 2022 Jul; 8(4):1031-1041. PubMed ID: 34688588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mirabegron on JJ stent-related symptoms: A multicentric study.
    Cinar O; Tanidir Y; Ozer S; Cizmeci S; Erbatu O; Ozdemir T; Girgin R; Ongun S; Ucer O; Kizilay F; Sen V; Irer B; Bozkurt O;
    Int J Clin Pract; 2021 Feb; 75(2):e13857. PubMed ID: 33230894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirabegron vs. solifenacin in control of endoscopically inserted ureteral stent-related symptoms.
    Abdelaziz AS; Salama NM; Ghoneem AM
    World J Urol; 2022 Aug; 40(8):2113-2119. PubMed ID: 35760910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.
    Wang J; Zhang X; Zhang T; Mu J; Bai B; Lei Y
    World J Urol; 2017 Nov; 35(11):1669-1680. PubMed ID: 28550362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Effectiveness of Single Pigtail Suture Stent on Patient Comfort: A Double-Blind Prospective Randomized Trial.
    Bostanci Y; Mercimek MN; Gulsen M; Ozden E; Yakupoglu YK; Sarikaya S
    J Laparoendosc Adv Surg Tech A; 2020 Nov; 30(11):1183-1188. PubMed ID: 32293992
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of ureteral stent type on patient symptoms as determined by the ureteral stent symptom questionnaire: a prospective, randomized, controlled study.
    Park HK; Paick SH; Kim HG; Lho YS; Bae S
    J Endourol; 2015 Mar; 29(3):367-71. PubMed ID: 25153249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamsulosin, Solifenacin, and Their Combination for the Treatment of Stent-Related Symptoms: A Randomized Controlled Study.
    Dellis AE; Papatsoris AG; Keeley FX; Bamias A; Deliveliotis C; Skolarikos AA
    J Endourol; 2017 Jan; 31(1):100-109. PubMed ID: 27809592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of delayed ureteral stents removal during the COVID-19 pandemic on the quality of life and psychological status of postoperative patients with urinary calculi].
    Lai JH; Wang Q; Ji JX; Wang MR; Tang XW; Xu KX; Xu T; Hu H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):857-864. PubMed ID: 37807740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.